{
    "title": "BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8479341/BioNTech-Pfizers-COVID-19-vaccine-shows-potential-human-trial.html",
    "date": "2020-07-01",
    "keywords": [
        "biontech",
        "vaccine",
        "covid19",
        "earlystage",
        "drug",
        "burger",
        "patricia",
        "pfizer",
        "testing",
        "shot",
        "trial",
        "infection",
        "approval",
        "review",
        "end",
        "biotech",
        "firm",
        "race",
        "world",
        "pandemic",
        "treatment",
        "promise",
        "moderna",
        "cansino",
        "fever",
        "dosage",
        "concentration",
        "group",
        "injection",
        "pain",
        "activity",
        "immune",
        "response",
        "cofounder",
        "executive",
        "officer",
        "sahin",
        "protection",
        "use",
        "institute",
        "technology",
        "analysis",
        "year",
        "stage",
        "bnt162b1",
        "dose",
        "side",
        "blood",
        "indicator",
        "bodys",
        "readiness",
        "validation",
        "industry",
        "followup",
        "europe",
        "july",
        "light",
        "germany",
        "manuscript",
        "april",
        "peer",
        "publication",
        "journal",
        "state",
        "investment",
        "fund",
        "temasek",
        "monday",
        "stake",
        "company",
        "reporting",
        "weiss",
        "editing",
        "david",
        "clarke"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}